Skip to content

Effects of Dancing on Cardiovascular and Functional Risk Factors in Older Women.

Effects of Dancing and Walking on Cardiovascular Risk Factors and Functional Capacity in Older Women: a Randomized Controlled Trial.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03262714
Enrollment
30
Registered
2017-08-25
Start date
2017-08-01
Completion date
2018-08-31
Last updated
2017-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Cardiovascular Risk Factor, Physical Activity

Keywords

Dance, walking, cardiovascular risk, functional capacity.

Brief summary

The goal of this randomized controlled trial is to investigate the effects of a dance intervention on cardiovascular risk factors and functional capacity of older women, comparing dancing to a walking exercise intervention and to an active control condition (stretching). The participants will include women between 60 and 80 years old, with body mass index inferior to 35 Kg /m2. The main outcome of this study is the peak oxygen consumption (VO2peak). The secondary outcomes are cardiovascular risk associated factors (C-reactive protein, TNF-alpha, lipid profile, etc) and functional performance (muscle strength and power, balance, gate ability, etc). The experimental design will include 3 parts: 1) Pre-intervention assessments: medical evaluation, fasting blood exams, maximum exercise test, assessments of body composition, balance, gate ability, muscular strength and power. 2) Period of interventions: patients will be randomized to one of the three following groups: dance, walking or stretching. The duration of the interventions will be 8 weeks, including 3 sessions per week for dance and walking, and once a week for the stretching group. Each session will last 60 min. 3) Post-intervention assessments: the same protocols of testing as pre-intervention.

Detailed description

The aging process is characterized by reductions of lean mass simultaneously to increases in visceral adipose tissue. Metabolically, this is related to insulin resistance and higher risk to develop cardiovascular diseases. Functionally, loss of strength and cardiorespiratory fitness may lead to early muscle fatigue onset, which may limit the performance of daily activities, and eventually lead to loss of independence with aging. Dancing has been used as a form of exercise to improve functional and metabolic outcomes during aging. However, the field lacks of randomized controlled trials (RCT) evaluating metabolic outcomes related to dance interventions, as well as comparisons of dancing with other types of exercise on functional performance and metabolic health of older adults. Therefore, the goal of this randomized controlled trial is to investigate the effects of a dance intervention on cardiovascular risk factors and functional capacity of older women, comparing dancing to a walking exercise intervention and to an active control condition (stretching). Additionally, we aim to investigate the acute cardiorespiratory responses of a dance session. The participants will include women between 60 and 80 years old, with body mass index inferior to 35 Kg /m2 and independent for performing daily activities. They should not be engaged in any type of regular physical activity in the past 6 months. Exclusion criteria will include type 2 diabetes mellitus, cardiovascular complications and neurodegenerative diseases. The main outcome of this study is the peak oxygen consumption (VO2peak), as it has been associated with both, cardiovascular risk and functional performance in aging individuals. The secondary outcomes are: (1) cardiovascular risk associated factors: C-reactive protein, TNF-alpha, triglycerides, total cholesterol, LDL-cholesterol, HDL-cholesterol, fasting glucose and insulin, and homeostatic model assessment of insulin resistance (HOMA-IR). (2) Functional performance: muscle strength and power, balance, gate ability and muscle quality. The experimental design will include 3 parts: 1) Pre-intervention assessments: medical evaluation, fasting blood exams, maximum exercise test, assessments of body composition, balance, gate ability, muscular strength and power. 2) Period of interventions: patients will be randomized in blocks (randomization.com), in accordance to their VO2peak , to one of the three following groups: dance, walking or control. The duration of the dance and walking interventions will be 8 weeks, including 3 sessions per week, each lasting 60 min. Dance classes will be performed in group in a dance studio, including a variety of rhythms such as salsa, jazz and aerobics. Walking sessions will be performed individually or in groups of two people, in a treadmill, at the gym. The control group will have 60min stretching classes once a week, also for 8 weeks. 3) Post-intervention assessments: the same protocols of testing of the pre-interventions assessments will be repeated. All the assessments and interventions will be held at the Laboratory of Research in Exercise (LAPEX-UFRGS).

Interventions

OTHERDance

Participants randomized to the dance group will take part in a dance intervention programme for 8 weeks, including 3 sessions per week, each lasting 60 min. Dance classes will be performed in group in a dance studio, including a variety of rhythms such as salsa, jazz and aerobics. The dance session wil include a warm up of 15 min (posture, join mobility and dance technique), a main part of 40 min (learning of specific choreographies and practice of moves across the floor), and a cool down of 5 min (muscle stretching and relaxation).

OTHERWalking

Participants randomized to the walking group will take part in a walking intervention programme for 8 weeks, including 3 sessions per week, each lasting 60 min. The walking session will include a warm up of 10 min (posture and join mobility), a main part of 40 min (walking on a treadmill with a heart rate corresponding to 60% of VO2peak), and a cool down of 10 min (muscle stretching and relaxation).

OTHERStretching

Participants randomized to the control group will take part in stretching classes, once a week, each lasting 60 min, also for 8 weeks. Stretching exercises for large muscle groups will be performed standing or in a match, holding the positions for a maximum of 10 s. There will be no music playing during the session.

Sponsors

Federal University of Rio Grande do Sul
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
60 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Women between 60 and 80 years old * BMI inferior to 35 kg/m2 * Independent for performing daily activities (OARS scale) * Not engaged in any type of regular exercise programme for the past 6 months

Exclusion criteria

* Type 2 diabetes mellitus, dyslipidemia, cardiovascular diseases or other non-controlled metabolic disorders * Chronic diseases such as fibromyalgia, cancer or neurodegenerative disorders * Bone, joints or muscle problems that could impair exercise performance * Not being able to perform the effort test in the first assessment session, abnormal electrocardiogram, or any other condition identified by the physician of the study that limit the engagement in an exercise training programme.

Design outcomes

Primary

MeasureTime frameDescription
Change in Peak Oxygen Consumption (VO2peak)Baseline and 8 weeksThe maximum capacity of oxygen consumption measured during an incremental exercise test.

Secondary

MeasureTime frameDescription
Change in LDL-CholesterolBaseline and 8 weeksLipid profile marker. Estimation of the LDL concentration will be calculate using the formula of Friedewald.
Change in HDL-CholesterolBaseline and 8 weeksLipid profile marker. It will be analyzed in plasma, by enzymatic colorimetric method, using an automatic analyzer (ROCHE, Cobas C111, Switzerland).
Change in C-reactive protein (CRP)Baseline and 8 weeksCardiovascular risk marker. It will be analyzed in plasma, using ELISA specific kits.
Change in Tumor necrosis factor alpha (TNF-alpha)Baseline and 8 weeksInflammatory marker. It will be analyzed in plasma, using ELISA specific kits.
Change in TriglyceridesBaseline and 8 weeksLipid profile marker. It will be analyzed in plasma, by enzymatic colorimetric method, using an automatic analyzer (ROCHE, Cobas C111, Switzerland).
Change in Fasting GlycemiaBaseline and 8 weeksGlycaemic profile marker. It will be analyzed in plasma, by enzymatic colorimetric method, using an automatic analyzer (ROCHE, Cobas C111, Switzerland).
Change in Fasting InsulinBaseline and 8 weeksGlycaemic profile marker. It will be measured in plasma, usin a high sensitivity enzyme-linked immunosorbent assay.
Change in HOMA-IRBaseline and 8 weeksGlycaemic profile marker. Homeostatic model of insulin resistance. It will be calculated according to the following formula: fasting insulin (microU/L) x fasting glucose (nmol/L)/22.5.
Change in Muscle StrengthBaseline and 8 weeksIsometric peak torque of the knee extensors will be measured using an isokinetic dynamometer (Cybex Norm, EUA).
Change in Muscle PowerBaseline and 8 weeksLower body muscle power will be measured by the performance of the counter movement jump in a force platform.
Change in Total CholesterolBaseline and 8 weeksLipid profile marker. It will be analyzed in plasma, by enzymatic colorimetric method, using an automatic analyzer (ROCHE, Cobas C111, Switzerland).
Change in Static BalanceBaseline and 8 weeksStatic balance will be measured by a single leg support balance test, performed with both legs, with the eyes open and closed.
Change in Dynamic BalanceBaseline and 8 weeksDynamic balance will be measured by the Time to Up ang Go (TUG) test.
Change in Gate abilityBaseline and 8 weeksGate ability will be measured in a 10m track, picking up objects and passing over obstacles.
Change in Body WeightBaseline and 8 weeksMeasurements of body weight will be measured in a digital scale.
Change in Waist CircumferenceBaseline and 8 weeksMeasurements of waist circumference will be performed with a measuring tape.
Change in Percentage of Body FatBaseline and 8 weeksMeasurements of skinfolds will be taken to calculate the percentage of body fat.
Change in Sit and Stand abilityBaseline and 8 weeksThe ability to sit and stand in a chair 5 times, as fast as possible.
Changes in Fall RiskBaseline and 8 weeksThe risk of fall will be measured by the performance in the TUG test.
Changes in the Fear of FallingBaseline and 8 weeksThe fear of falling will be analyzed by the Falls Efficacy Scale-International Brazil (FES-I-Brazil).
Changes in Quality of LifeBaseline and 8 weeksQuality of life will be analyzed by the questionary WHOQOL (World Health Organization Quality of Life.
Change in Muscle QualityBaseline and 8 weeksEcho intensity of the quadriceps will be analyzed by ultrasound images.

Countries

Brazil

Contacts

Primary ContactJosianne Rodrigues-Krause, MSc.
rodrigues.krause@ufrgs.br5551 999101821
Backup ContactAlvaro Reischak-Oliveira, PhD.
alvaro.oliveira@ufrgs.br55-51-3308-5862

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026